These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7692197)

  • 21. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
    Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
    Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibodies against hepatitis C virus. Experience with a second generation test].
    Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
    G E N; 1991; 45(3):183-9. PubMed ID: 1726913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease.
    Hada H; Koide N; Hanafusa T; Sakaguchi K; Shinji T; Sasaki S; Oka T; Takayama N; Yumoto Y; Tsuji T
    Acta Med Okayama; 1992 Oct; 46(5):365-70. PubMed ID: 1279946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serodiagnostic assay of hepatitis C virus infection using viral proteins expressed in Escherichia coli.
    Mori S; Ohkoshi S; Hijikata M; Kato N; Shimotohno K
    Jpn J Cancer Res; 1992 Mar; 83(3):264-8. PubMed ID: 1316340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 27. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
    Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T
    Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
    Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
    J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 31. Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1.
    El-Diwany R; Cohen VJ; Mankowski MC; Wasilewski LN; Brady JK; Snider AE; Osburn WO; Murrell B; Ray SC; Bailey JR
    PLoS Pathog; 2017 Feb; 13(2):e1006235. PubMed ID: 28235087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
    Weiner AJ; Geysen HM; Christopherson C; Hall JE; Mason TJ; Saracco G; Bonino F; Crawford K; Marion CD; Crawford KA
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3468-72. PubMed ID: 1314389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
    Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term persistence of IgM antibodies to HCV in chronic hepatitis C.
    Brillanti S; Foli M; Perini P; Masci C; Miglioli M; Barbara L
    J Hepatol; 1993 Aug; 19(1):185-6. PubMed ID: 7507953
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins.
    da Silva Cardoso M; Siemoneit K; Sturm D; Krone C; Moradpour D; Kubanek B
    J Med Virol; 1998 May; 55(1):28-34. PubMed ID: 9580883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-HCV antibodies against the structural and nonstructural antigens of hepatitis C in people seropositive in the second generation test].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(3):159-65. PubMed ID: 1284256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
    Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
    J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.